BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) announced the successful treatment of four cancer patients at prestigious hospitals in Italy using BSD’s innovative new MicroThermX® Microwave Ablation System.
The treatments were conducted within a four-day period and were attended by numerous key Italian physicians. Med-Italia Biomedica (Med-Italia), one of the largest interventional radiology/oncology distributors in Italy, purchased the MicroThermX® system and coordinated the delivery of the treatments.
The four participating hospitals included some of Italy’s leading hospitals: Ospedaliera Spedali Civili in Brescia, one of the largest hospitals in Northern Italy; Istituto Clinico Humanitas in Rozzano, a teaching center for the University of Milan’s International Medical School; Instituto Europeo Di Oncologia in Milano, a leading cancer treatment hospital and home to Umberto Veronesi, MD, one of Italy’s most respected cancer surgeons; and Ospedale di San Giovanni Battista in Torino, the oldest hospital in Torino and the largest hospital in Piedmont.
BSD personnel monitored the procedures and provided training to Med-Italia’s Director, Sales Manager, Engineering Manager, and 24 of its sales representatives. All 24 sales representatives are now actively selling the MicroThermX® systems throughout Italy.
Med-Italia is a major distributor and manufacturer of products designed for the interventional radiology and oncology market in Italy. Med-Italia is an exclusive distributor in Italy for a number of large medical companies, selling strategically adjacent products to the same clinicians and market that will be targeted for the MicroThermX® System.
Source: BSD Medical Corporation